Hafner, HNowotny, BEpidemiology of early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 1995; 245:80–92.
Remschmidt, HTheisen, FMSchizophrenia and related disorders in children and adolescents. J Neural Transm Suppl. 69)2005; 121–41.
Schimmelmann, BGSchmidt, SJCarbon, MCorrell, CUTreatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach. Curr Opin Psychiatry 2013; 26:219–30.
Pedersen, CBMors, OBertelsen, AWaltoft, BLAgerbo, EMcGrath, JJ et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry 2014; 71:573–81.
Clemmensen, LVernal, DLSteinhausen, HCA systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry 2012; 12:150.
Rapoport, JLGogtay, NChildhood onset schizophrenia: support for a progressive neurodevelopmental disorder. Int J Dev Neurosci 2011; 29:251–8.
Sharma, ANeely, JCamilleri, NJames, AGrunze, HLe Couteur, AIncidence, characteristics and course of narrow phenotype paediatric bipolar I disorder in the British Isles. Acta Psychiatr Scand 2016; 134:522–32.
Merikangas, KRHe, JPBurstein, MSwanson, SAAvenevoli, SCui, L et al. Lifetime prevalence of mental disorders in U. S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2010; 49:980–9.
Post, RMLuckenbaugh, DALeverich, GSAltshuler, LLFrye, MASuppes, T et al. Incidence of childhood-onset bipolar illness in the USA and Europe. Br J Psychiatry 2008; 192:150–1.
Rao, PMoore, JKStewart, RRunions, KBear, NWong, JW et al. Bipolar disorder in children and adolescents: diagnostic inpatient rates from 2000 to 2013 in Germany. Int J Bipolar Disord 2016; 4:23.
Iyer, SNBoekestyn, LCassidy, CMKing, SJoober, RMalla, AKSigns and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories. Psychol Med 2008; 38:1147–56.
Sönmez, NRøssberg, JIEvensen, JBarder, HEHaahr, UTen Velden Hegelstad, W et al. Depressive symptoms in first-episode psychosis: a 10-year follow-up study. Early Interv Psychiatry 2016; 10:227–33.
Romm, KLMelle, IThoresen, CAndreassen, OARossberg, JISevere social anxiety in early psychosis is associated with poor premorbid functioning, depression, and reduced quality of life. Compr Psychiatry 2012; 53:434–40.
Sonmez, NRomm, KLAndreasssen, OAMelle, IRossberg, JIDepressive symptoms in first episode psychosis: a one-year follow-up study. BMC Psychiatry 2013; 13:106.
Friis, SMelle, IJohannessen, JORøssberg, JIBarder, HEEvensen, JH et al. Early predictors of ten-year course in first-episode psychosis. Psychiatr Serv 2016; 67:438–43.
Pathak, PWest, DMartin, BCHelm, MEHenderson, CEvidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001–2005. Psychiatr Serv 2010; 61:123–9.
Pagsberg, AKTarp, SGlintborg, DStenstrøm, ADFink-Jensen, ACorrell, CU et al. Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis. J Am Acad Child Adolesc Psychiatry 2017; 56:191–202.
Pagsberg, AKJeppesen, PKlauber, DGJensen, KGRudå, DStentebjerg-Olesen, M et al. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. Lancet Psychiatry 2017; 4:605–18.
Stafford, MRMayo-Wilson, ELoucas, CEJames, AHollis, CBirchwood, M et al. Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysis. PLoS One 2015; 10:e0117166.
BenAmor, LAntipsychotics in pediatric and adolescent patients: a review of comparative safety data. Affect Disord Suppl. 138)2012; S22–30.
Kumra, SOberstar, JVSikich, LFindling, RLMcClellan, JMVinogradov, S et al. Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophr Bull 2008; 34:60–71.
Nesvåg, RHartz, IBramness, JGHjellvik, VHandal, MSkurtveit, SMental disorder diagnoses among children and adolescents who use antipsychotic drugs. Eur Neuropsychopharmacol 2016; 26:1412–8.
Munk-Jorgensen, POkkels, NGolberg, DRuggeri, MThornicroft, GFifty years' development and future perspectives of psychiatric register research. Acta Psychiatr Scand 2014; 130:87–98.
The Norwegian Directorate of Health Nasjonal faglig retningslinje for utredning, behandling og oppfølging av personer med psykoselidelserHelsedirektoratet 2013IS-1957. (in Norwegian).
World Health Organizatioin The ICD-10 Classification of mental and behavioural disorders Clinical descriptions and diagnostic guidelines 1992, World Health Organization Geneva, Switzerland.
ATC Classification Index with DDDs Oslo: WHO Collaborating Centre for Drug Statistics Methodology. [Available from: http://www.whocc.no/].
Kuhl, JOGLaursen, TMThorup, ANordentoft, MThe incidence of schizophrenia and schizophrenia spectrum disorders in Denmark in the period 2000–2012. A register-based study. Schizophr Res 2016; 176:533–9.
Okkels, NVernal, DLJensen, SOMcGrath, JJNielsen, REChanges in the diagnosed incidence of early onset schizophrenia over four decades. Acta Psychiatr Scand 2013; 127:62–8.
Kringlen, ETorgersen, SCramer, VA Norwegian psychiatric epidemiological study. Am J Psychiatry 2001; 158:1091–8.
Ten Have, MVollebergh, WBijl, RNolen, WABipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 2002; 68:203–13.
Alonso, JAngermeyer, MCBernert, SBruffaerts, RBrugha, TSBryson, H et al. ESEMeD/MHEDEA 2000 investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) project: prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004; 420:21–27 Suppl.
Niarchou, MZammit, SLewis, GThe Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort as a resource for studying psychopathology in childhood and adolescence: a summary of findings for depression and psychosis. Soc Psychiatry Psychiatr Epidemiol 2015; 50:1017–27.
Ryles, FMeyer, TDAdan-Manes, JMacmillan, IScott, JA systematic review of the frequency and severity of manic symptoms reported in studies that compare phenomenology across children, adolescents and adults with bipolar disorders. Int J Bipolar Disord 2017; 5:4.
Bramness, JGGrøholt, BEngeland, AFuru, KThe use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004–2007 – a prescription database study. J Affect Disord 2009; 117:208–11.
Gjerden, PBramness, JGTvete, IFSlordal, LThe antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004–2015. Eur J Clin Pharmacol 2017;73(9):1173–9.
Nesvåg, RJönsson, EGBakken, IJKnudsen, GPBjella, TDReichborn-Kjennerud, T et al. The quality of severe mental disorder diagnoses in a national health registry as compared to research diagnoses based on structured interview. BMC Psychiatry 2017; 17:93.